Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2009

Open Access 01-12-2009 | Case report

A levonorgestrel-releasing intrauterine system embedded in the omentum in a woman with abdominal pain: a case report

Authors: Asimakis Pappas, Siddesh Shambhu, Kevin Phillips, Kate Guthrie

Published in: Journal of Medical Case Reports | Issue 1/2009

Login to get access

Abstract

Introduction

The Mirena intrauterine system has been licensed as a contraceptive in the United Kingdom since May 1995. The use of an intrauterine system as a primary method of contraception among women has been slowly increasing over the last few years and they now account for about 3% of contraceptive use in England. The Mirena intrauterine system now also has a license for the management of idiopathic menorrhagia. Women may be informed that the rate of uterine perforation associated with intrauterine contraceptive use is low (0-2.3 per 1000 insertions). The rate of perforation reported with the Mirena intrauterine system in a large observational cohort study was 0.9 per 1000 insertions.

Case presentation

In this case report, the diagnosis of an intraperitoneal Mirena intrauterine system was noted nearly four years after its insertion, despite the patient having had a vaginal hysterectomy and admissions to hospital in the interim with complaints of abdominal pain.

Conclusion

This case report demonstrates clearly that whenever there is a question of a intrauterine system having fallen out following an ultrasound scan report showing an empty uterus, clinicians should also perform an abdominal X-ray.
Appendix
Available only for authorised users
Literature
5.
go back to reference Harrison-Woolrych M, Ashton J, Coulter D: Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?. Contraception. 2003, 67: 53-56. 10.1016/S0010-7824(02)00417-1.CrossRefPubMed Harrison-Woolrych M, Ashton J, Coulter D: Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?. Contraception. 2003, 67: 53-56. 10.1016/S0010-7824(02)00417-1.CrossRefPubMed
6.
go back to reference World Health Organization (WHO): Mechanism of Action, Safety and Efficacy of Intrauterine Devices (WHO Technical Report Series No. 753). 1987, Geneva, Switzerland: WHO, 1-91. World Health Organization (WHO): Mechanism of Action, Safety and Efficacy of Intrauterine Devices (WHO Technical Report Series No. 753). 1987, Geneva, Switzerland: WHO, 1-91.
7.
go back to reference Caliskan E, Öztürk N, Dilbaz BÖ, Dilbaz S: Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care. 2003, 8: 150-155. 10.1080/713604445.CrossRefPubMed Caliskan E, Öztürk N, Dilbaz BÖ, Dilbaz S: Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care. 2003, 8: 150-155. 10.1080/713604445.CrossRefPubMed
8.
go back to reference Zhou L, Harrison-Woolrych M, Coulter DM: Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiol Drug Saf. 2003, 12: 371-377. 10.1002/pds.875.CrossRefPubMed Zhou L, Harrison-Woolrych M, Coulter DM: Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiol Drug Saf. 2003, 12: 371-377. 10.1002/pds.875.CrossRefPubMed
11.
go back to reference Royal College of Obstetricians and Gynaecologists (RCOG): The Management of Menorrhagia in Secondary Care. National Evidence- Based Clinical Guidelines. 1999, London, UK: RCOG Royal College of Obstetricians and Gynaecologists (RCOG): The Management of Menorrhagia in Secondary Care. National Evidence- Based Clinical Guidelines. 1999, London, UK: RCOG
12.
go back to reference Romer T, Schmidt T, Foth D: Pre- and postoperative hormonal treatment in patients with hysteroscopic surgery. Contributions to Gynecology and Obstetrics. 2000, 20: 1-12. full_text.CrossRefPubMed Romer T, Schmidt T, Foth D: Pre- and postoperative hormonal treatment in patients with hysteroscopic surgery. Contributions to Gynecology and Obstetrics. 2000, 20: 1-12. full_text.CrossRefPubMed
14.
go back to reference Maia H, Maltez A, Coelho G, Athayde C, Coutinho EM: Insertion of Mirena after Endometrial Resection in Patients with Adenomyosis. The Journal of the American Association of Gynecologic Laparoscopists. 2003, 10 (4): 512-516. 10.1016/S1074-3804(05)60158-2.CrossRefPubMed Maia H, Maltez A, Coelho G, Athayde C, Coutinho EM: Insertion of Mirena after Endometrial Resection in Patients with Adenomyosis. The Journal of the American Association of Gynecologic Laparoscopists. 2003, 10 (4): 512-516. 10.1016/S1074-3804(05)60158-2.CrossRefPubMed
15.
go back to reference Ozgun MT, Batukan C, Serin IS, Ozcelik B, Basbug M, Dolanbay M: Surgical management of intra-abdominal mislocated intrauterine devices. Contraception. 2007, 75 (2): 96-100. 10.1016/j.contraception.2006.09.011.CrossRefPubMed Ozgun MT, Batukan C, Serin IS, Ozcelik B, Basbug M, Dolanbay M: Surgical management of intra-abdominal mislocated intrauterine devices. Contraception. 2007, 75 (2): 96-100. 10.1016/j.contraception.2006.09.011.CrossRefPubMed
Metadata
Title
A levonorgestrel-releasing intrauterine system embedded in the omentum in a woman with abdominal pain: a case report
Authors
Asimakis Pappas
Siddesh Shambhu
Kevin Phillips
Kate Guthrie
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2009
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-3-9301

Other articles of this Issue 1/2009

Journal of Medical Case Reports 1/2009 Go to the issue